This speaker is hidden and is only visible in a proposal
Cindy Eckert (formerly Whitehead)
CEO and Founder of Sprout Pharmaceuticals & The Pink Ceiling
Cindy Eckert is an expert Entrepreneur and Angel Investor with total exits over $1.5 Billion. After selling her pharmaceutical company, Cindy launched the The Pink Ceiling business incubator for women led or women focused businesses.
Bio
A self-made serial entrepreneur and vocal advocate for women, Cindy defies convention. In her industry, in her companies, in her outcomes. Her work today in The Pinkubator continues to break barriers by investing in and mentoring other women together same outcomes. She’s on a mission to make women really rich. You cannot miss Cindy. Everything she touches turns to PINK!
Over a distinguished 24-year career in healthcare, in only the last 10 years she has built and sold two businesses for more than $1.5B. First Slate Pharmaceuticals, which redefined log acting testosterone treatment for men then Sprout Pharmaceuticals which broke through with the first ever FDA approved drug for low sexual desire in women—dubbed “female Viagra” by the media. After selling the company for $1B in 2015, she successfully fought together drug back and launch it on her own terms.
Cindy has made waves, and made her own success, creating mission-driven companies that deliver big. Her results have become a widely covered business success story featured in major media outlets. She is most proud of helping others take command. The profoundly positive impact those companies have made in people’s lives is what keeps her coming back for more.
Keynotes
Featured Keynote
-
Cindy Eckert Helps Women Smash the Pink Ceiling
Cindy Eckert, CEO and founder of Sprout Pharmaceuticals and The Pink Ceiling, can help capture attention thanks to her forceful self-confidence (in this case that of a self-made billionaire) as well as her signature hot-pink attire. In the past 10 years alone, Eckert started and sold two businesses for a total of more than $1.5 billion. The first was Slate Pharmaceuticals, which redefined testosterone treatment for men, and then Sprout Pharmaceuticals, which developed the precedent-setting Addyi, the first FDA-approved drug for low sexual desire in women, frequently referred to as the "female Viagra."
Let's find your perfect speaker!
Share your vision and let us curate the voices that bring it to life.